These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 22775065)
1. Evaluation of ocular manifestations and blindness in HIV/AIDS patients in a tertiary care hospital in South India. Ganekal S; Jhanji V; Dorairaj S; Nagarajappa A Ocul Immunol Inflamm; 2012 Oct; 20(5):336-41. PubMed ID: 22775065 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of ocular manifestations and blindness in HIV/AIDS patients on HAART in a tertiary care hospital in western India. Shah SU; Kerkar SP; Pazare AR Br J Ophthalmol; 2009 Jan; 93(1):88-90. PubMed ID: 18952644 [TBL] [Abstract][Full Text] [Related]
3. Ophthalmic manifestations of HIV infections in India in the era of HAART: analysis of 100 consecutive patients evaluated at a tertiary eye care center in India. Gharai S; Venkatesh P; Garg S; Sharma SK; Vohra R Ophthalmic Epidemiol; 2008; 15(4):264-71. PubMed ID: 18780260 [TBL] [Abstract][Full Text] [Related]
4. The HIV RNA Levels of Plasma and Ocular Fluids in AIDS Patients with Ophthalmic Infections. Hsu WM; Chiou SH; Chen SS; Shyong MP; Ho CK; Chen SJ; Wu CC; Kung SH; Chi CW Ophthalmologica; 2004; 218(5):328-32. PubMed ID: 15334014 [TBL] [Abstract][Full Text] [Related]
5. Seven years of HAART impact on ophthalmic management of HIV-infected patients. Kahraman G; Krepler K; Franz C; Ries E; Maar N; Wedrich A; Rieger A; Dejaco-Ruhswurm I Ocul Immunol Inflamm; 2005; 13(2-3):213-8. PubMed ID: 16019681 [TBL] [Abstract][Full Text] [Related]
6. Prevalence of cytomegalovirus retinitis in Tanzanians with low CD4 levels. Nirwoth JP; Hall AB; Lewallen S Br J Ophthalmol; 2011 Apr; 95(4):460-2. PubMed ID: 21106992 [TBL] [Abstract][Full Text] [Related]
7. Ocular manifestations of HIV infection. Jabs DA Trans Am Ophthalmol Soc; 1995; 93():623-83. PubMed ID: 8719695 [TBL] [Abstract][Full Text] [Related]
8. Loss of cytomegalovirus-specific CD4+ T cell responses in human immunodeficiency virus type 1-infected patients with high CD4+ T cell counts and recurrent retinitis. Komanduri KV; Feinberg J; Hutchins RK; Frame RD; Schmidt DK; Viswanathan MN; Lalezari JP; McCune JM J Infect Dis; 2001 Apr; 183(8):1285-9. PubMed ID: 11262214 [TBL] [Abstract][Full Text] [Related]
9. Characterization of reactivation of cytomegalovirus retinitis in patients healed after treatment with highly active antiretroviral therapy. Song MK; Karavellas MP; MacDonald JC; Plummer DJ; Freeman WR Retina; 2000; 20(2):151-5. PubMed ID: 10783947 [TBL] [Abstract][Full Text] [Related]
10. [Diagnosis and treatment of eye diseases associated with HIV infection and AIDS]. Geng S; Ye JJ; Liu LQ; Xu HY; Wang WW; Wang SR Zhonghua Yan Ke Za Zhi; 2009 Dec; 45(12):1093-8. PubMed ID: 20193432 [TBL] [Abstract][Full Text] [Related]
11. HIV-related eye disease in patients presenting to a tertiary care government hospital in Turkey. Akçakaya AA; Sargın F; Erbil HH; Aybar A; Sadigov F; Yaylalı SA; Akçay G; Ozgüneş N Ocul Immunol Inflamm; 2012 Jun; 20(3):158-62. PubMed ID: 22515816 [TBL] [Abstract][Full Text] [Related]
12. [Indications for eye examination of HIV patients--screening parameters for cytomegalovirus retinitis]. Gellrich MM; Lagrèze WD; Rump JA; Hansen LL Klin Monbl Augenheilkd; 1996; 209(2-3):72-8. PubMed ID: 8992086 [TBL] [Abstract][Full Text] [Related]
13. Longitudinal study of the ocular complications of AIDS: 1. Ocular diagnoses at enrollment. Jabs DA; Van Natta ML; Holbrook JT; Kempen JH; Meinert CL; Davis MD; Ophthalmology; 2007 Apr; 114(4):780-6. PubMed ID: 17258320 [TBL] [Abstract][Full Text] [Related]
14. Characteristics of untreated AIDS-related cytomegalovirus retinitis. II. Findings in the era of highly active antiretroviral therapy (1997 to 2000). Holland GN; Vaudaux JD; Shiramizu KM; Yu F; Goldenberg DT; Gupta A; Carlson M; Read RW; Novack RD; Kuppermann BD; Am J Ophthalmol; 2008 Jan; 145(1):12-22. PubMed ID: 18154751 [TBL] [Abstract][Full Text] [Related]
15. Effect of highly active antiretroviral therapy (HAART) on the natural history of ocular manifestations in HIV-infected children. Esposito S; Porta A; Bojanin J; Gualtieri L; Cesati L; Vismara E; Principi N Eye (Lond); 2006 May; 20(5):595-7. PubMed ID: 16410815 [TBL] [Abstract][Full Text] [Related]
16. Cytomegalovirus retinitis: the neglected disease of the AIDS pandemic. Heiden D; Ford N; Wilson D; Rodriguez WR; Margolis T; Janssens B; Bedelu M; Tun N; Goemaere E; Saranchuk P; Sabapathy K; Smithuis F; Luyirika E; Drew WL PLoS Med; 2007 Dec; 4(12):e334. PubMed ID: 18052600 [TBL] [Abstract][Full Text] [Related]
17. Prevalence and clinical management of cytomegalovirus retinitis in AIDS patients in Shanghai, China. Shi Y; Lu H; He T; Yang Y; Liu L; Zhang R; Zheng Y; Shen Y; Zhang Y; Zhang Z BMC Infect Dis; 2011 Nov; 11():326. PubMed ID: 22115120 [TBL] [Abstract][Full Text] [Related]
18. Ophthalmic manifestations and risk factors for mortality of HIV patients in the post-highly active anti-retroviral therapy era. Lai TY; Wong RL; Luk FO; Chow VW; Chan CK; Lam DS Clin Exp Ophthalmol; 2011 Mar; 39(2):99-104. PubMed ID: 20796263 [TBL] [Abstract][Full Text] [Related]
19. Tuberculoid leprosy and cytomegalovirus retinitis as immune restoration disease in a patient with AIDS. Kumar S; Ghosh MK; Sarkar S; Mallik S; Biswas PN; Saha B Int J Infect Dis; 2012 Feb; 16(2):e146-8. PubMed ID: 22169463 [TBL] [Abstract][Full Text] [Related]
20. Prevalence of ocular manifestations of HIV/AIDS in the highly active antiretroviral therapy (HAART) era: a different spectrum in Central South China. Luo J; Jing D; Kozak I; Huiming Z; Siying C; Yezhen Y; Xin Q; Luosheng T; Adelman RA; Forster SH Ophthalmic Epidemiol; 2013 Jun; 20(3):170-5. PubMed ID: 23713918 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]